The purpose of this research was to investigate recent tendencies regarding the utilization of healthcare services and the consumption of prescribed medications by patients who suffer from sleeplessness. Between January 2010 and December 2016, we analyzed the data from the National Patient Sample that was provided by the Health Insurance Review and Assessment Service in order to establish the healthcare utilization of patients who had been identified with sleeplessness (International Classification of Diseases10 codes G470, F510). During the course of the research conducted over a period of seven years, there were 87,470 individuals who participated in this study and received medical treatment on at least one occasion. Comorbidities, socioeconomic statistics, and patterns in healthcare utilization were analyzed. Patterns in healthcare utilization included Korean and Western medicine (KM and WM, respectively) treatments utilised. Each year, there was an increase in the number of individuals requesting treatment for sleeplessness at WM or KM. 73% of the patients in the sample were adults older than 45 years old, and the number of female patients outnumbered the male patients. The most frequent treatment for KM was acupuncture, which accounted for 65.29 percent of all cases, while the most common treatment for WM was examination (49.31 percent of all cases). Sedatives and hypnotics were used the most frequently in pharmacological treatment (41.08 percent), followed by antianxiety medications (19.50 percent), and then medicines related to the digestive system and metabolism (7.77 percent). In the WM population, the most prevalent complications were mental health disorders (50.56%), whereas in the KM population, musculoskeletal illnesses (35.67%) were the most common. Code G470 was utilised more frequently than code F510, and the distinction between the two was more noticeable in KM than it was in WM. Both medical practitioners and academic researchers will benefit greatly from the discoveries that were found.